524661 — Welcure Drugs and Pharmaceuticals Balance Sheet
0.000.00%
- IN₹83.15m
- IN₹1.12bn
- IN₹245.50m
- 30
- 100
- 52
- 68
Annual balance sheet for Welcure Drugs and Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | — | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.475 | 0.66 | 0.012 | 0.216 | 196 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.255 | — | 0.002 | 0 | 190 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.73 | 0.66 | 0.059 | 0.318 | 1,821 |
| Net Property, Plant And Equipment | — | — | 0.568 | 0.209 | 0.303 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 0.73 | 0.968 | 15.3 | 13.7 | 2,670 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.036 | 0.038 | 0.136 | 0.306 | 413 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.036 | 0.038 | 0.136 | 0.306 | 1,645 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 0.694 | 0.93 | 15.2 | 13.4 | 1,025 |
| Total Liabilities & Shareholders' Equity | 0.73 | 0.968 | 15.3 | 13.7 | 2,670 |
| Total Common Shares Outstanding |